36 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... outcomes in HFrEF on GDMT ... outcomes in HFrEF on GDMT ... visualabstract #table ... #CVD #CKD
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy - Initiation Strategies

 •
Approach: ACE, ARB, ARNI ... -2 Inhibitor → ARNI ... Guideline #management #GDMT
Guidelines Directed medical therapy for Heart Failure 

Satyendra Dhar, MD, @DharSaty

#HFrEF #GDMT #sodium-glucosecotransporter-2inhibitors #SGLT2i #reninangiotensinaldosteronesysteminhibitors
DharSaty #HFrEF #GDMT ... angiotensinreceptorblockers #ARB #ARNI
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy
 • Beta-blocker
 • ACE,
• ACE, ARB, ARNI ... Guideline #management #GDMT
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Medical Therapy (GDMT ... ) in HFrEF and CKD ... pillars of HFrEF GDMT ... disease: ACEI, ARB, ARNI ... #CKD #HFrEF #management
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Definitions of AKI, CKD ... Kidney Disease (CKD ... per 1.73 m2 • Stable ... /CKD • No structural ... damage #AKI #CKD
HFrEF: Guideline Directed Medical Therapy

"Must Be On"
 • ACEI, ARB, or ARNI AND select Beta Blockers
ACEI, ARB, or ARNI ... ACEI or ARB • ARNI ... chf #cardiology #GDMT
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Comorbidities: • Stable ... Dissection • CKD ... , DM, ESRD, PKD ... #pharmacology #table
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
Pharmacology #Opiates #CKD ... #Gabapentin #Table
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics